Table 1.

Characteristics of the 61 patients analyzed


Characteristic

Value*
Sex, no. M/no. F patients   32/29  
Median age at transplantation, y (range)   9 (1-24)  
Underlying disease  
    Malignant   37 (61)  
    Nonmalignant   24 (39)  
Stem-cell source  
    Bone marrow   43 (70)  
    Peripheral blood   14 (23)  
    Cord blood   4 (7)  
Donor type  
    Sibling   22 (36)  
    Unrelated   27 (44)  
    Haploidentical relative   12 (20)  
Donor/recipient HCMV serostatus  
    D+/R+  28 (46)  
    D-/R+  11 (18)  
    D+/R-  18 (29)  
    D-/R-  4 (7)  
Conditioning regimen  
    TBI based   27 (44)  
    Non-TBI based   34 (56)  
GvHD prophylaxis  
    CS-A   13 (21)  
    CS-A + MTX   36 (59)  
    T-cell depletion   12 (20)  
Administration of ALG  
    Yes   27 (44)  
    No   34 (56)  
GvHD grade  
    0 to I   44 (72)  
    II to IV   17 (28)  
Steroid therapy  
    Yes   26 (43)  
    No
 
35 (57)
 

Characteristic

Value*
Sex, no. M/no. F patients   32/29  
Median age at transplantation, y (range)   9 (1-24)  
Underlying disease  
    Malignant   37 (61)  
    Nonmalignant   24 (39)  
Stem-cell source  
    Bone marrow   43 (70)  
    Peripheral blood   14 (23)  
    Cord blood   4 (7)  
Donor type  
    Sibling   22 (36)  
    Unrelated   27 (44)  
    Haploidentical relative   12 (20)  
Donor/recipient HCMV serostatus  
    D+/R+  28 (46)  
    D-/R+  11 (18)  
    D+/R-  18 (29)  
    D-/R-  4 (7)  
Conditioning regimen  
    TBI based   27 (44)  
    Non-TBI based   34 (56)  
GvHD prophylaxis  
    CS-A   13 (21)  
    CS-A + MTX   36 (59)  
    T-cell depletion   12 (20)  
Administration of ALG  
    Yes   27 (44)  
    No   34 (56)  
GvHD grade  
    0 to I   44 (72)  
    II to IV   17 (28)  
Steroid therapy  
    Yes   26 (43)  
    No
 
35 (57)
 

TBI indicates total body irradiation; CS-A, cyclosporine-A; MTX, methotrexate; ALG, antilymphocyte globulin; and GvHD, graft-versus-host disease.

*

Values are expressed as number of patients (percent of patients) unless otherwise indicated.

Close Modal

or Create an Account

Close Modal
Close Modal